Recursion Pharmaceuticals (RXRX.MX) Q2 2025 Earnings

5MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-10.88
-9.5
-8.11
-6.73

Details

Expected EPS
-10.1496684
Actual EPS
-9.83495
Surprise EPS
0.31
Surprise Percent
+3.1%

Description

Recursion Pharmaceuticals (RXRX.MX) has reported earnings of -9.83495 per share for Q2 2025.

0 Comments

Share your thoughts